arrow
J

Juan G. Abraldeṣ

University of Alberta
H指数:97
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Expert Delphi consensus on surrogate endpoints for treatment assessment in metabolic dysfunction-associated steatohepatitis

代谢功能障碍相关脂肪性肝炎治疗评估的替代终点专家德尔菲共识

2025-12-060
PRE
The ANTICIPATE-NASH Models Stratify Better the Risk of Clinical Events Than Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients With Advanced Chronic Liver Disease

与组织学相比,在代谢功能障碍相关的脂肪性肝病晚期慢性肝病患者中,预期-NASH模型对临床事件风险的分层效果更好。

2025-11-100
OAAI
Refining the Baveno VII criteria for clinically significant portal hypertension: an individual-patient data meta-analysis

优化Baveno VII标准以用于临床显著门静脉高压症:一项基于个体患者数据的meta分析

2025-10-240
PRE
Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease

靶向抑制致病共生菌毒力因子可缓解酒精性肝病

2025-05-280
PRE
Comparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol-Associated Hepatitis: A Global Cohort Study

预测酒精相关性肝炎对皮质类固醇反应的动态模型之间的比较: 一项全球队列研究

2025-02-180
OAAI
Nonalcohol-related Cirrhosis Leads to Higher 6-week Mortality After Acute Variceal Bleeding Than Alcohol-related Cirrhosis

非酒精性肝硬化导致的急性静脉曲张破裂出血后6周死亡率高于酒精性肝硬化。

2024-12-140
PRE
The impact of colonization by multidrug resistant bacteria on graft survival, risk of infection, and mortality in recipients of solid organ transplant: systematic review and meta-analysis

多药耐药菌定植对实体器官移植受者移植物存活、感染风险和死亡率的影响: 系统综述和荟萃分析

2024-10-011
OA
Viral antibody response predicts morbidity and mortality in alcohol-associated hepatitis
2024-09-250
PRE
Relationship between updated MELD and prognosis in alcohol-associated hepatitis: Opportunities for more efficient trial design
2024-08-010
OAAI
Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease

非酒精性脂肪性肝病患者肝脏相关事件的护理点无创预测

2024-08-0114
PRE